KDR and cancer: Results from preclinical and clinical studies have confirmed that both VEGF and VEGFR-2-mediated signalling and angiogenesis make great contributions to the pathogenesis of a variety of malignant tumors and provide potential therapeutic targets for antiangiogenic treatment [2].